Evidence map›Paper›PMID 41074487›Full record

ArticleFuture science OA2025

Validation of the Kazakh-language version of the 8-item Morisky Medication Adherence Scale in patients with arterial hypertension.

Gulnaz Nuskabayeva, Kanatzhan Kemelbekov, Dilbar Aidarbekova, Yerbolat Saruarov, Nursultan Nurdinov, Kumissay Babayeva, Ugilzhan Tatykayeva, Elmira Iskandirova, Dinara Nemetova, Philip Morisky and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gulnaz NuskabayevaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Kanatzhan KemelbekovSouth Kazakhstan Medical Academy, Shymkent City, Kazakhstan.
Dilbar AidarbekovaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Yerbolat SaruarovKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Nursultan NurdinovKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Kumissay BabayevaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Ugilzhan TatykayevaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Elmira IskandirovaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Dinara NemetovaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Philip MoriskyUniversity of La Verne, La Verne, CA, USA.
Ainash OshibayevaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.
Karlygash SadykovaKhoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan City, Kazakhstan.ORCID 0000-0002-9120-8565

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effectiveness of pharmacological therapies relies not only on the intrinsic efficacy of medicines, but also medication adherence, the extent to which patients follow their prescribed regimens. Patients with chronic conditions, such as hypertension, are at an increased risk of exhibiting poor medication adherence. Therefore, identifying patients with poor medication adherence is an important aspect of treatment success. RESEARCH DESIGN AND

methodsThe present study aims to translate and adapt the Morisky Medication Adherence Scale (MMAS-8), a self-reporting questionnaire to assess patients' adherence to prescribed therapy.

resultsThe study validated the translated questionnaire and assessed its psychometric properties among a cohort of 400 patients with arterial hypertension in Turkistan region in southern Kazakhstan. The findings of the present study show that the Kazakh version of the MMAS-8 possesses high validity, reliability, and internal consistency, thereby confirming its appropriateness as a reliable tool for assessing medication adherence among patients with arterial hypertension in Kazakhstan.

conclusionThe psychometric properties of the Kazakh adaptation were comparable to those of the original English version and other validated non- English versions of the MMAS-8.

Indexed as

arterial hypertensionKazakh-language validationMedication adherenceMorisky scale (MMAS-8)psychometric evaluation

Identifiers

PMID41074487
PMCPMC12520102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.